Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy
Table 2
Changes in the lipid profile and blood pressure levels in 34 patients undergoing anti-TNF-alpha-adalimumab therapy due RA refractory to conventional DMARDs.